Defunct Company
Total Trials
67
As Lead Sponsor
54
As Collaborator
13
Total Enrollment
9,980
NCT01565291
A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers
Phase: Early Phase 1
Role: Lead Sponsor
Start: Jun 30, 2007
Completion: Jan 31, 2008
NCT01564706
A Study of 18F-AV-45 in Healthy Volunteers
Phase: Phase 1
Start: Oct 31, 2007
NCT01565330
A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers
Start: Mar 31, 2008
Completion: Aug 31, 2008
NCT01565343
A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers
Start: Apr 30, 2008
Completion: Apr 30, 2009
NCT00702143
A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
Phase: Phase 2
Start: Jun 30, 2008
Completion: Dec 31, 2008
NCT00857415
Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain
Phase: Phase 3
Start: Dec 31, 2008
Completion: May 31, 2010
NCT00857506
Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)
Start: Jan 31, 2009
Completion: Dec 31, 2011
NCT00857532
Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients
Completion: Nov 30, 2011
NCT00855868
Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals
Start: Mar 31, 2009
Completion: Jan 31, 2011
NCT00958997
Positron Emission Tomography (PET) Imaging of Pancreatic Beta-Cell Mass in Healthy and Type 1 Diabetic Patients
Phase: N/A
Role: Collaborator
Start: Aug 31, 2009
Completion: May 31, 2012
NCT01890343
Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.
Start: Sep 30, 2009
Completion: Apr 30, 2013
NCT01518374
Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
Start: Dec 31, 2009
Completion: May 3, 2017
NCT01447719
Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07
Start: Mar 31, 2010
Completion: Jul 31, 2011
NCT01503944
A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
Phase: Phase 1/2
NCT01565356
Evaluation of PET Scan Timing Relative to AV-45 Injection Time
NCT01515384
A Trial of 18F-AV-133 Positron Emission Tomography (PET)
Start: Jun 30, 2010
Completion: Feb 28, 2013
NCT01565369
Evaluation of Physician Training Methods to Read Florbetapir-PET Scans
Start: Jan 31, 2011
NCT01565382
Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)
Start: Feb 28, 2011
Completion: Feb 28, 2011
NCT01400425
Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline
Start: Jul 31, 2011
Completion: Jul 31, 2012
NCT01550549
Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans
Start: Aug 31, 2011
Completion: Sep 30, 2011
NCT01619709
Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage
Start: Jan 31, 2012
Completion: Jun 30, 2017
NCT01550484
A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
Phase: Phase 2/3
Start: Apr 30, 2012
Completion: Mar 31, 2016
NCT01606488
Effects of Brain Beta-Amyloid on Postoperative Cognition
Phase: Phase 4
Start: May 31, 2012
Completion: Jun 30, 2026
NCT01723488
A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808
Start: Jul 31, 2012
Completion: Mar 31, 2013
NCT01733355
A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807
NCT01660815
A Study of Florbetapir (18F) in Japanese Healthy Volunteers
Start: Aug 31, 2012
Completion: Jan 31, 2013
NCT01662882
A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
Start: Oct 31, 2012
NCT01703702
Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
Completion: Apr 30, 2015
NCT01710371
Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls
Start: Dec 31, 2012
Completion: Sep 30, 2015
NCT01760005
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
Completion: Jul 31, 2028
NCT04623242
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
Completion: Mar 6, 2020
NCT04474405
Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects
Start: Aug 16, 2013
Completion: Dec 9, 2013
NCT01946243
The Feasibility of Florbetapir Quantitation
Start: Aug 31, 2013
Completion: Apr 30, 2014
NCT01992380
A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects
Start: Nov 13, 2013
Completion: May 30, 2014
NCT02016560
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects
Start: Dec 31, 2013
Completion: Jul 28, 2017
NCT02051790
Evaluation of Reader Training Processes
Start: Mar 31, 2014
Completion: Aug 31, 2014
NCT02107599
The Feasibility of Florbetapir Quantitation in Europe
Completion: May 31, 2014
NCT02120664
Florbetapir Calibration to the Centiloid Scale
Start: Apr 30, 2014
NCT02051764
Imaging Characteristics of a Follow-up 18F-AV-1451 Scan
Start: May 31, 2014
Completion: Dec 31, 2016
NCT02164643
Longitudinal Study of Brain Amyloid imaGing in MEMENTO
Start: Jun 10, 2014
Completion: Oct 9, 2019
NCT02079766
18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
Start: Jun 30, 2014
Completion: Oct 31, 2015
NCT02167594
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Start: Aug 12, 2014
Completion: Jul 11, 2016
NCT02029547
Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians
Start: Oct 31, 2014
Completion: May 31, 2015
NCT04468347
Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease
Completion: Feb 28, 2018
NCT02278367
Clinical Evaluation of Flortaucipir F 18
Start: Dec 31, 2014
Completion: Jun 26, 2019
NCT02336360
Augmenting Flortaucipir Dosimetry Estimates
Start: Jan 31, 2015
Completion: Jun 30, 2015
NCT02486250
Online Neuropsychological Test Validation Project With Imaging Pilot
Completion: Mar 31, 2021
NCT02278354
Tau Imaging in Professional Fighters
Start: Feb 18, 2015
Completion: Feb 3, 2017
NCT02516046
18F-AV-1451 Autopsy Study
Start: Sep 30, 2015
Completion: Jul 15, 2018
NCT02512029
18F-AV-1451 PET Imaging in TBI
Start: Oct 31, 2015
Completion: Apr 30, 2017
NCT03143374
PET Tau - Neurodegenerative Disease Imaging
Start: Aug 23, 2016
Completion: Sep 30, 2030
NCT02795780
Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05
Start: Aug 31, 2016
Completion: Aug 28, 2017
NCT02850146
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
Completion: Sep 29, 2023
NCT02918539
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Start: Oct 31, 2016
Completion: Oct 18, 2017
NCT02350634
18F-AV-1451 High Resolution Autopsy Study
Start: Nov 26, 2016
Completion: Jun 16, 2017
NCT02958670
Imaging Tau Deposition in the Brain of Elderly Subjects
Start: Nov 30, 2016
Completion: Dec 31, 2029
NCT03040427
The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis
Start: Jan 31, 2017
Completion: Aug 21, 2019
NCT03052972
Flortaucipir 18F PET Imaging in BIOCARD Study
Start: Mar 23, 2017
Completion: Aug 17, 2018
NCT03040713
Flortaucipir PET Imaging in Subjects With FTD
Start: Apr 11, 2017
Completion: Oct 24, 2018
NCT03322462
Tau Screening Study in Patients With Early Symptomatic AD
Start: Nov 21, 2017
Completion: Aug 31, 2018
NCT03467477
Tau Screening Study in Subjects With Early Symptomatic AD
Start: Mar 8, 2018
Completion: Nov 15, 2018
NCT03019757
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
Start: Aug 30, 2018
Completion: Dec 31, 2026
NCT03901092
A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation
Start: Mar 26, 2019
Completion: Apr 26, 2019
NCT03901105
Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease
Start: Mar 28, 2019
Completion: Apr 28, 2019
NCT04708613
University of Pittsburgh Brain Health Initiative
Start: Nov 18, 2019
NCT04721756
Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging
Start: Apr 12, 2022
Completion: Apr 30, 2024
NCT05775601
18F-LY3950321-01 Biodistribution and Safety Study
Start: Feb 28, 2023
Completion: Apr 4, 2023